Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Thursday, October 27, 2016

New London TMAU Patient Support Group. Karen writes.

London Metabolic Unit TMAU Patient Support Group.
Started in July 2016 by the Adult Metabolic Unit Staff.
Expected to meet 3-4 times a year.

Karen attended the recently started TMAU patient support group started by UCLH adult metabolic unit. So far the group has met twice (July and October).
This is the 3rd known  Adult Metabolic Unit to start a TMAU patient support group. The other 2 known groups also started this year, at the metabolic units in Dublin (Ireland) and Birmingham (UK). MEBO Research UK Public Relations Director (volunteer).

Message from Karen about the recently started TMAU patient support group started by UCLH this July. So far has met twice.

Summary of TMAU Patient Group Meeting on 21.10.16 at University College London Hospital 3-5pm

The TMAU patient group at UCLH was set up in July 2016 by members of Dr Lachmann’s staff team. At the current time, it is open to those patients of Dr. Lachmann who have received a positive diagnosis of TMAU at his clinic. It is hoped, however, that the group will be able to expand to include other sufferers of malodour in the future.

The main activity of the session, led by a clinical psychologist, involved group members analysing the skills/attitudes they adopted in order to challenge a particular difficulty brought on by having TMAU. A few people described the initiatives they took in specific situations, for example, their actions during incidents of workplace bullying, or their preparations to improve confidence prior to attending a social event. Other group members identified, and then discussed, the empowering language used to describe these actions.

The group discussed the issue of NHS GPs refusing to refer patients for TMAU testing even when the patient has presented a page of information (printed from  ‘how to get tested’) during the consultation. It was decided that further raising awareness is needed, and it was agreed that an information leaflet should be designed for this purpose. The leaflet will be displayed in the Charles Dent Metabolic Unit of the National Hospital for Neurology and Neurosurgery and can also be distributed to GP practices.

Subsequent discussions were cut short by time, but they included: sharing strategies to deal with bullying at work/school/college and comparing the efficacy of various supplements such as chlorophyll, Body Mint, charcoal, riboflavin.

Finally, it was agreed that the patient group needs to be led and managed by its own members and that volunteers from our own community can take part in organising the content of sessions.

So we need a logo!
Our task is to create a very succinct, informative TMAU leaflet which features a simple logo. The graphic could be designed to identify the group as a strong, united community, which will support fellow sufferers. If you would like to contribute a logo/graphic for this leaflet, please let us know.

If you would like to contribute to the wording of the leaflet, make corrections/improvements, or make suggestions as to what should be included on it, please contact At present, we have these ideas for information:

TMAU (Trimethylaminuria) is a metabolic disorder in which the sufferer’s body emits the malodorous gas trimethylamine via the skin, hair, and/or breath.
Although the disorder is not yet curable, patients take many measures (dietary restrictions etc.) to try to diminish the pungent odours they produce.
Diagnosis of the disorder in the UK is available via the NHS through a GP referral to a metabolic specialist such as Dr. R. Lachmann. See : for further details.

If you would like to help find a solution for this disorder, please go to international charity MEBO Research :
MEBO Research website
MEBO blog (this site)

get New Posts by EMAIL : Enter your email address :

A EURORDIS and NORD Member Organization


Kaneoheboy said...

What happened with the Resveratrol studies?

Feb 14, 2020, 4:33:00 PM
Post a Comment